研究者詳細 - 和田　優貴

研究等業績 - その他 - 和田　優貴

分割表示 39 件中 1 - 20 件目／全件表示 >>

Post-brachytherapy patient management: the need for integrated health information systems in radiation safety and mortality tracking

Naoko Mori, Yuki Wada, Satoshi Kumagai, Yu Mori, Hiroshi Sakamoto, Shunji Mugikura

Japanese Journal of Radiology ( Springer Science and Business Media LLC ) 2025年04月

DOI

The usefulness of combining narrow-band imaging with magnifying endoscopy and 18F-fluorodeoxyglucose positron emission tomography for predicting the depth of invasion in superficial esophageal squamous cell carcinoma

So Kodama, Kenta Watanabe, Tamotsu Matsuhashi, Sho Fukuda, Yosuke Shimodaira, Yushi Nagaki, Akiyuki Wakita, Yusuke Sato, Tomoki Tozawa, Yuki Wada, Naoko Mori, Hiroshi Nanjo, Katsunori Iijima

Esophagus ( Esophagus ) 2025年03月 [査読有り]

DOI

「課題先進県」の秋田県で考えるこれからの放射線治療

和田優貴

JASTRO NEWSLETTER 155 ( 1 ) 37 - 39 2025年03月

その他記事単著

In Regard to Hirose and Sato

Yuki Wada, Naoko Mori

International Journal of Radiation Oncology Biology Physics ( International Journal of Radiation Oncology Biology Physics ) 120 ( 3 ) 2024年11月 [査読有り]

速報，短報，研究ノート等（学術雑誌）国内共著

DOI

緩和照射普及のための秋田大学放射線治療科での取組みと工夫

和田優貴

JASTRO NEWSLETTER 152 ( 152 ) 38 - 39 2024年06月

その他記事単著

胸部X線画像の診方 -理学療法士の立場から-

大倉和貴, 和田優貴

秋田理学療法 31 ( 1 ) 11 - 17 2024年03月 [査読有り]

速報，短報，研究ノート等（大学，研究機関紀要）国内共著

放射線治療部門の水害対策秋田豪雨の経験から

和田優貴

JASTRO NEWSLETTER 150 ( 150 ) 24 - 25 2023年12月

その他記事単著

In Regard to Kil et al

Yuki Wada, Tetsugaku Shinozaki, Toshiki Murata, Satoshi Kumagai, Noriko Takagi, Naoko Mori

Advances in Radiation Oncology ( Elsevier BV ) 8 ( 5 ) 101293 - 101293 2023年09月 [査読有り]

速報，短報，研究ノート等（学術雑誌）国内共著

DOI

Re.: “A Systematic Review of the Safety and Efficacy of Stenting of the Inferior Vena Cava”

Noriko Takagi, Yuri Wada, Naoko Mori

European Journal of Vascular and Endovascular Surgery ( Elsevier BV ) 66 ( 2 ) 2023年04月 [査読有り]

速報，短報，研究ノート等（学術雑誌）

DOI

Regarding “Final Analysis of Diagnostic Endoscopic Resection Followed by Selective Chemoradiotherapy for Stage I Esophageal Cancer”

Yuki Wada, Naoko Mori

Gastroenterology ( Elsevier BV ) 165 ( 2 ) 518 - 519 2022年11月 [査読有り]

速報，短報，研究ノート等（学術雑誌）国内共著

DOI

PALLIATIVE REIRRADIATION WITH AN ACCUMULATED DOSE OF 80 GY FOR PAINFUL BRACHIAL PLEXUS METASTASIS AFTER 60 GY IRRADIATION FOR LYMPH NODE METASTASIS OF BREAST CNACER: A CASE REPORT

Yuki Wada, Akira Anbai, Noriko Takagi, Tomoki Tozawa, Satoshi Kumagai, Eriko Okuyama, Kento Hatakeyama, Makoto Niwa, Manabu Hashimoto

Akita Journal of Medicine ( 秋田医学会 ) 48 ( 5 ) 47 - 53 2021年11月

The rare condition of brachial plexus metastasis (BPM) from malignant carcinoma causes extreme pain and can limit activities of daily living. A few reports have indicated that palliative irradiation is an effective and safe treatment for BPM ; however, the efficacy and safety of reirradiation for BPM are not well-known. In the present report, we describe the case of a patient with BPM of breast cancer who had a history of receiving 60 Gy of irradiation in 30 fractions to bilateral subclavian areas to treat lymph node metastases, developed extremely painful BPM in the primary irradiated area, and underwent further irradiation with 20 Gy in five fractions. This palliative reirradiation initially resulted in significant pain relief, and the tumors reduced in size immediately after the treatment. Regrowth of the tumors and recurrence of the pain occurred five months after irradiation ; however, further irradiation was not administered as it could be associated with a high risk of plexopathy or myelopathy. This case report describes the tolerability and effectiveness of reirradiation for BPM, the decision process of reirradiation, and the usefulness of modern diagnostic imaging for deciding radiation field and technique to deliver safe and effective reirradiation.

DOI CiNii Research

Selective transcatheter arterial infusion of cisplatin in palliative intent for residual bulky tongue cancers after intravenous systemic chemotherapy combined with radiotherapy: Two case reports

Yuki Wada, Aoi Otaka, Takaharu Miyauchi, Naoko Fukui, Hiromoto Kimura, Manabu Hashimoto

Journal of Clinical Images and Medical Case Reports 2 ( 5 ) 1333 2021年09月

高齢者における食道癌手術の現状と課題高齢患者に対する食道切除術の有効性に関する検討(Analysis whether esophagectomy provides advantages for elderly patients)

脇田晃行, 本山悟, 佐藤雄亮, 藤田啓, 煙山紘平, 安倍明, 和田優貴, 南谷佳弘

日本食道学会学術集会プログラム・抄録集 ( (NPO)日本食道学会 ) 75回 57 - 57 2021年09月

Neoadjuvant chemoradiotherapy followed by esophagectomy with three-field lymph node dissection for thoracic esophageal squamous cell carcinoma patients with clinical stage iii and with supraclavicular lymph node metastasis

Sato Y.

Cancers ( Cancers ) 13 ( 5 ) 1 - 14 2021年03月

DOI

The usefulness of the combination of d-dimer and soluble fibrin monomer complex for diagnosis of venous thromboembolism in psychiatric practice: a prospective study

Takeshima M.

Vascular Health and Risk Management ( Vascular Health and Risk Management ) 17 239 - 246 2021年

DOI PubMed

Outcomes of Definitive Chemoradiotherapy for Stage IVa (T4b vs. N4) Esophageal Squamous Cell Carcinoma Based on the Japanese Classification System: A Retrospective Single-Center Study

Yuki Wada, Akira Anbai, Noriko Takagi, Satoshi Kumagai, Eriko Okuyama, Hiroshi Nanjo, Yusuke Sato, Satoru Motoyama, Manabu Hashimoto

Cancers ( MDPI AG ) 13 ( 1 ) 8 - 8 2020年12月

The differences in prognoses or progression patterns between T4b non-N4 and non-T4b N4 esophageal squamous cell carcinoma post chemoradiotherapy (CRT) is unclear. This study compared the outcomes of CRT for stage IVa esophageal squamous cell carcinoma according to T/N factors. We retrospectively identified 66 patients with stage IVa esophageal squamous cell carcinoma who underwent definitive CRT at our center between January 2009 and March 2013. The treatment outcomes, i.e., progression patterns, prognostic factors, and toxicities based on version 5.0 of the National Cancer Institute Common Terminology Criteria for Adverse Events, were studied. The patients (56 men and 10 women) had a median age of 67 (range: 37–87) years. The T/N classifications were T4b non-N4 (28/66), non-T4b N4 (24/66), and T4b N4 (14/66). Objective response was achieved in 57 patients (86.4%, (95% confidence interval, 74.6–94.1%)). There were no significant differences between the T/N groups in terms of overall survival, progression-free survival, and progression pattern. We found no significant differences in prognoses or progression patterns among patients with T4b non-N4, non-T4b N4, and T4b N4 esophageal squamous cell carcinoma. Thus, it seems impractical to modify CRT regimens based on T/N factors.

DOI

Modern evidence and future prospects of external body radiation therapy for lung oligometastases of breast cancer

Wada Y.

Translational Cancer Research ( Translational Cancer Research ) 9 ( 8 ) 5077 - 5086 2020年08月

DOI

Modern evidence and future prospects of external body radiation therapy for lung oligometastases of breast cancer

Yuki Wada, Manabu Hashimoto

Translational Cancer Research ( AME Publishing Company ) 9 ( 8 ) 5077 - 5086 2020年08月

DOI

YC-1 sensitizes the antitumor effects of boron neutron capture therapy in hypoxic tumor cells

Harada T.

Journal of radiation research ( Journal of radiation research ) 61 ( 4 ) 524 - 534 2020年07月